Ragini Yeeravalli

Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal–epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs

Kanakaraju Manupati, Neha R. Dhoke, Tanusree Debnath et al. · FEBS Journal · 2017 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Crismita Dmello, Junfei Zhao, Li Chen et al. · Nature Communications · 2023 · 46 citations · Full text

Medicine, Immunology, Oncology +17

In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents

Sudhan Debnath, Kanakaraju Manupati, Minarul Islam et al. · Computational Biology and Chemistry · 2019 · 27 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis

Kanakaraju Manupati, Ragini Yeeravalli, Komal Kaushik et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2021 · 24 citations

Medicine, Cell Biology, Oncology +14

Total Synthesis of Desmethyl Jahanyne and Its Lipo-Tetrapeptide Conjugates Derived from Parent Skeleton as BCL-2-Mediated Apoptosis-Inducing Agents

Shivakrishna Kallepu, M. Kavitha, Ragini Yeeravalli et al. · ACS Omega · 2018 · 19 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17